CCND1 and cancer: Activation of the RAS-MEK-ERK pathway, along with ERBB2 in hormonal-driven cancers (such as breast) and the Wnt pathway [8–10] have also been associated with higher CCND1 expression, that may occur through increasing its transcription [11, 12].